Bleakley Financial Group, LLC Lyell Immunopharma, Inc. Transaction History

Bleakley Financial Group, LLC

  • $3.28 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$1.3 - $3.01 $9,659 - $22,364
-7,430 Reduced 28.75%
18,412 $26.7 Million
Q1 2024

May 08, 2024
SELL
$1.71 - $3.07 $38,074 - $68,356
-22,266 Reduced 46.28%
25,842 $57.6 Million
Q4 2023

Jan 25, 2024
BUY
$1.39 - $2.35 $66,870 - $113,053
48,108 New
48,108 $93.3 Million

Others Institutions Holding LYEL

# of Institutions
121
Shares Held
142M
Call Options Held
18.1K
Put Options Held
200
View Full List

About Lyell Immunopharma, Inc.

LYEL Quotes by TradingView
  • Ticker LYEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 247,824,992
  • Market Cap $161M
  • Description
  • Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...
More about LYEL
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email